GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Additional Paid-In Capital

ACME Laboratories (DHA:ACMELAB) Additional Paid-In Capital : BDT5,128 Mil(As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Additional Paid-In Capital?


ACME Laboratories's quarterly additional paid-in capital stayed the same from Jun. 2023 (BDT5,128 Mil) to Sep. 2023 (BDT5,128 Mil) and stayed the same from Sep. 2023 (BDT5,128 Mil) to Mar. 2024 (BDT5,128 Mil).

ACME Laboratories's annual additional paid-in capital stayed the same from Jun. 2021 (BDT5,128 Mil) to Jun. 2022 (BDT5,128 Mil) and stayed the same from Jun. 2022 (BDT5,128 Mil) to Jun. 2023 (BDT5,128 Mil).

ACME Laboratories Additional Paid-In Capital Historical Data

The historical data trend for ACME Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Additional Paid-In Capital Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
Get a 7-Day Free Trial 5,127.60 5,127.60 5,127.60 5,127.60 5,127.60

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,127.60 5,127.60 5,127.60 5,127.60 5,127.60

ACME Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

ACME Laboratories Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Additional Paid-In Capital
Comparable Companies
DHA:ORIONINFU DHA:AFCAGRO DHA:BEACONPHAR DHA:BXPHARMA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
Website
https://www.acmeglobal.com
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories Headlines

No Headlines